Huang’s research found that asporin, released by cardiac fibroblasts, was able to attenuate TGFβ signaling, thereby inhibiting the progression of myocardial fibrosis (Huang et al., 2022). The gene discussed is TGFB1; the disease is Myocardial fibrosis.